[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 1, Issue 2 (Spring - 2013) ::
Shefaye Khatam 2013, 1(2): 41-44 Back to browse issues page
May Measuring of Plasma Amyloid Beta in Healthy Subjects be used as a Prognostic Factor Pointing to a Risk of Pending Alzheimer’s Disease?
Fereshteh Sedaghat *
a. Shefa Neuroscience Research Center, Tehran, Iran. b. Sedaghat Outpatient Memory Clinic, Mashhad, Iran. c. Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. d. Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece. , fereshsedag@yahoo.com
Abstract:   (6061 Views)

Introduction: Disease modifying treatment strategies for Alzheimer’s disease (AD) have led to a severe need for finding biomarkers to be able to establish a reliable diagnosis at a very early stage and also to follow up the patient and their response to therapy. Amyloids β (Αβ) which predominate in amyloid plaques constitute one major neuropathologic hallmark in AD, are produced by all types of cells in the central nervous system and almost all cells in peripheral tissues. Increased plasma level of this peptide is reported in prodromal stage of AD, in mild cognitive impairment. Conclusion: Different genetic, imaging and biochemical studies suggest that increased plasma Aβ can begin many years before the onset of symptoms in AD, indicating that it does not require preexisting neural abnormalities. It remains to be verified if the proof of plasma Aβ in clinically healthy subjects represents a prognostic factor pointing to a risk of pending AD.

Keywords: Amyloid, beta-Peptides, Alzheimer Disease, Hippocampus, Cognition, Learning
Full-Text [PDF 1351 kb]   (1190 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Neurology



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sedaghat F. May Measuring of Plasma Amyloid Beta in Healthy Subjects be used as a Prognostic Factor Pointing to a Risk of Pending Alzheimer’s Disease?. Shefaye Khatam. 2013; 1 (2) :41-44
URL: http://shefayekhatam.ir/article-1-36-en.html


Volume 1, Issue 2 (Spring - 2013) Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.06 seconds with 32 queries by YEKTAWEB 3961